Academic And Industry Experience You Can Trust
Dr. Kurt Weingand trained in veterinary medicine and surgery at the University of Missouri and received his D.V.M degree in 1980. He worked in a companion animal veterinary clinic for a year then enrolled as a National Cancer Institute trainee in the graduate program at Colorado State University and obtained a Ph.D. degree in Pathology in 1984.
Dr. Weingand’s first academic appointment was at the Wake Forest University School of Medicine where he led research on mechanisms of coronary artery atherosclerosis. Dr. Weingand became a Diplomate of the American College of Veterinary Pathology by earning board certification as a veterinary clinical pathologist in 1985. He then became an Assistant Professor of Laboratory Medicine at Kansas State University’s College of Veterinary Medicine leading research on body fat distribution as a risk factor for coronary artery disease and providing clinical pathology instruction and service in the veterinary teaching hospital.
Dr. Weingand joined Procter & Gamble (P&G) in 1988 to lead toxicologic pathology research in support of pre-clinical safety assessments. In this role, he led an international task force that developed harmonized guidelines for clinical pathology testing in pre-clinical toxicity and safety studies.
Dr. Weingand transferred to P&G Health Care in 1993 as a clinical scientist to lead the conduct of human clinical trials on a variety of health care products (Metamucil, Pepto-Bismol, NyQuil, Vicks). In 1997, he led product development of a new non-drug topical analgesic product that culminated in the launch of ThermaCare HeatWraps in 2000.
In 2001, Dr. Weingand began his leadership role in the P&G Health Sciences Institute to lead technical outreach of new research information and serve as the external spokesperson for OTC Health Care brands. He advanced to Associate Director of Global External Relations where he led commercial innovation for the launch of Prilosec OTC in 2004. In 2006, he was appointed to lead P&G Pet Care’s alternative animal models development program and site operations in research & development at the Lewisburg Innovation Center.
Dr. Weingand accepted responsibility for P&G Pet Care’s Global External Relations organization in 2007 to lead Scientific Communications, Professional Relations, Public Relations, Consumer Relations, Corporate Reputation, Government Relations, and Crisis Management for the Iams and Eukanuba brands. He led the P&G Pet Care global crisis team during the 2007 Menu Foods pet food recall.
Dr. Weingand is currently the President of SciComPro-LLC®, a privately held life sciences consulting firm. Dr. Weingand is currently a Principal Investigator in clinical trials of medical devices and a clinical pathologist for preclinical safety assessment of drugs and biologics in development.
SciComPro-LLC® has strategic alliances with select businesses to offer the world-class services with high quality and maximum value.
- 55 KRC in Cincinnati, Ohio is owned by Clear Channel Broadcasting and serves the tri-state area with talk and information. 55KRC is the home for Brian Thomas, Glenn Beck, Rush Limbaugh, and Sean Hannity. 55KRC also provides how to advice each weekend from your garden, home or your car from our experts Ron Wilson, Gary Sullivan, Marilyn Harris and Dale Donovan. For more information, see www.55krc.com.
- Vet Path Services, Inc. for pathology in preclinical safety studies. See www.vetpathservicesinc.com.
- Davidson Communications & External Relations, LLC for environmental issues and public relations. See www.davidsoncer.com.
- Community Research for clinical research studies. See www.communityresearch.com.
- Goodwyn IRB for clinical research reviews. See www.goodwynirb.com.
